左心房结构相关指标对心房颤动导管消融术后复发的影响

王喆; 陈英伟; 董建增

doi:10.13201/j.issn.1001-1439.2020.09.002

左心房结构相关指标对心房颤动导管消融术后复发的影响

- 1 郑州大学第一附属医院心内科(郑州, 450052);
- 2 首都医科大学附属北京安贞医院心内科
基金项目:
国家重点研发计划项目(No:2016YFC1301000)

详细信息

通讯作者: 董建增,E-mail:jzdong@zzu.edu.cn

中图分类号: R541.7

收稿日期: 2020-04-15

Summary of left atrial structure-related indexes on the effect of atrial fibrillation recurrence after catheter ablation

- 1 Department of Cardiology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China;
- 2 Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University

More Information

Corresponding author: DONG Jianzeng, E-mail: jzdong@zzu.edu.cn

Received Date: 15 April 2020

摘要

摘要: 心房颤动(房颤)是严重危害人类健康的心血管疾病之一,导管射频消融术是症状性房颤患者的一线治疗方式,但消融术后复发是不可忽视的问题。左心房内结构复杂,左心房大小、纤维化、形状、低电压,左心耳大小,肺静脉大小和解剖变异、肺静脉间嵴及左心耳嵴结构等与房颤的发生发展密切相关。本文将对影响房颤导管消融术后复发的左心房结构的相关指标作一综述,供临床参考与借鉴。
- 心房颤动 /
- 射频消融 /
- 左心房结构 /
- 复发
Abstract: Atrial fibrillation(AF) is one of the most serious cardiovascular diseases,and catheter ablation is the main treatment method for patients with AF.However,recurrence after ablation is a problem that cannot be ignored,because left atrial(LA) structure is complex.LA size,fibrosis,the shape,low voltage,size of left atrial appendage(LAA),pulmonary veins size and anatomic variation,ridge between pulmonary vein,LAA ridge and so on are closely related to the development of AF.This review is to illuminate the left atrial structure related indicators affect recurrence after AF ablation for clinical reference.
- atrial fibrillation /
- radiofrequency ablation /
- left atrial structure /
- recurrence

HTML全文

参考文献(36)

[1]	Correction to:Heart disease and stroke statistics-2018 update:a report from the American Heart Association[J].Circulation,2018,137(12):e493.
[2]	Guo Y,Lane DA,Wang L,et al.Mobile health technology to improve care for patients with atrial fibrillation[J].J Am Coll Cardiol,2020,75(13):1523-1534.
[3]	Pitek-Koziej K,Hoda J,Tyrak K,et al.Anatomy of the left atrial ridge (coumadin ridge) and possible clinical implications for cardiovascular imaging and invasive procedures[J].J Cardiovasc Electrophysiol,2020,31(1):220-226.
[4]	January CT,Wann LS,Calkins H,et al.2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation [J].Circulation,2019,140(2):e125-e151.
[5]	Pallisgaard JL,Gislason GH,Hansen J,et al.Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014:a nationwide Danish cohort study[J].Eur Heart J,2018,39(6):442-449.
[6]	Packer DL,Mark DB,Robb RA,et al.Effect of catheter ablation vs antiarrhythmic drug therapy on mortality,stroke,bleeding,and cardiac arrest among patients with atrial fibrillation:The CABANA Randomized Clinical Trial[J].JAMA,2019,321(13):1261-1274.
[7]	Marrouche NF,Brachmann J,Andresen D,et al.Catheter ablation for atrial fibrillation with heart failure[J].N Engl J Med,2018,378(5):417-427.
[8]	王秀玉,张虹.心房颤动性心肌病导管消融治疗[J].临床心血管病杂志,2018,34(6):545-548.
[9]	Kranert M,Shchetynska-Marinova T,Liebe V,et al.Recurrence of atrial fibrillation in dependence of left atrial volume index[J].In Vivo,2020,34(2):889-896.
[10]	Fujino T,Yuzawa H,Kinoshita T,et al.Clinical factors associated with a successful catheter ablation outcome in elderly patients with atrial fibrillation[J].Int Heart J,2020,61(1):21-28.
[11]	Sohns C,Sohns JM,Vollmann D,et al.Left atrial volumetry from routine diagnostic work up prior to pulmonary vein ablation is a good predictor of freedom from atrial fibrillation[J].Eur Heart J Cardiovasc Imaging,2013,14(7):684-691.
[12]	胡晓,谷阳,蒙涛,等.维生素D水平、左房容积指数与阵发性房颤患者射频消融术后复发的相关性研究[J].中国循证心血管医学杂志,2019,11(1):59-62.
[13]	Istratoaie S,Rocu R,Cismaru G,et al.The impact of pulmonary vein anatomy on the outcomes of catheter ablation for atrial fibrillation[J].Medicina (Kaunas),2019,55(11):727.
[14]	Kim TH,Park J,Park JK,et al.Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation,but not paroxysmal atrial fibrillation:an analysis of over 600-patients[J].Int J Cardiol,2014,176(3):841-846.
[15]	Lopez-Canoa JN,Baluja A,Couselo-Seijas M,et al.Plasma FABP4 levels are associated with left atrial fat volume in persistent atrial fibrillation and predict recurrence after catheter ablation[J].Int J Cardiol,2019,292:131-135.
[16]	den Uijl DW,Cabanelas N,Benito EM,et al.Impact of left atrial volume,sphericity,and fibrosis on the outcome of catheter ablation for atrial fibrillation[J].J Cardiovasc Electrophysiol,2018,29(5):740-746.
[17]	Marrouche NF,Wilber D,Hindricks G,et al.Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation:the DECAAF study[J].JAMA,2014,311(5):498-506.
[18]	魏飞宇,范洁,高田,等.miR-199-3p通过靶向调控SP1促进成纤维细胞增殖对心房颤动心房重构的影响[J].临床心血管病杂志,2020,36(6):523-530.
[19]	Liu Y,Niu XH,Yin X,et al.Elevated circulating fibrocytes is a marker of left atrial fibrosis and recurrence of persistent atrial fibrillation[J].J Am Heart Assoc,2018,7(6):e008083.
[20]	Huo Y,Gaspar T,Pohl M,et al.Prevalence and predictors of low voltage zones in the left atrium in patients with atrial fibrillation[J].Europace,2018,20(6):956-962.
[21]	Huang D,Li JB,Zghaib T,et al.The extent of left atrial low-voltage areas included in pulmonary vein isolation is associated with freedom from recurrent atrial arrhythmia[J].Can J Cardiol,2018,34(1):73-79.
[22]	Bieging ET,Morris A,Wilson BD,et al.Left atrial shape predicts recurrence after atrial fibrillation catheter ablation[J].J Cardiovasc Electrophysiol,2018,29(7):966-972.
[23]	Bis Bisbal F,Alarcón F,Ferrero-de-Loma-Osorio A,et al.Left atrial geometry and outcome of atrial fibrillation ablation:results from the multicentre LAGO-AF study[J].Eur Heart J Cardiovasc Imaging,2018,19(9):1002-1009.
[24]	杨廷杰,张菲斐.心房颤动射频消融术后左心房球形度预测复发的价值[J].临床心血管病杂志,2018,34(10):1006-1010.
[25]	He Y,Zhang B,Zhu F,et al.Transesophageal echocardiography measures left atrial appendage volume and function and predicts recurrence of paroxysmal atrial fibrillation after radiofrequency catheter ablation[J].Echocardiography,2018,35(7):985-990.
[26]	Hozawa M,Morino Y,Matsumoto Y,et al.3D-computed tomography to compare the dimensions of the left atrial appendage in patients with normal sinus rhythm and those with paroxysmal atrial fibrillation[J].Heart Vessels,2018,33(7):777-785.
[27]	郑桂安,林春艺,翁兰,等.左心耳体积对心房颤动导管射频消融术后复发的预测价值[J].中华心血管病杂志,2017,45(11):924-929.
[28]	Kiuchi K,Yoshida A,Takei A,et al.Topographic variability of the left atrium and pulmonary veins assessed by 3D-CT predicts the recurrence of atrial fibrillation after catheter ablation[J].J Arrhythm,2015,31(5):286-92.
[29]	Li B,Ma H,Guo H,et al.Pulmonary vein parameters are similar or better predictors than left atrial diameter for paroxysmal atrial fibrillation after cryoablation[J].Braz J Med Biol Res,2019,52(9):e8446.
[30]	贺吟歌,李凌,袁义强,等.肺静脉开口面积与持续性心房颤动射频消融术后复发的关系?[J].中国心脏起搏与心电生理杂志,2019,33(2):29-33.
[31]	Hunter RJ,Ginks M,Ang R,et al.Impact of variant pulmonary vein anatomy and image integration on long-term outcome after catheter ablation for atrial fibrillation[J].Europace,2010,12(12):1691-1697.
[32]	林明宽,梁柳丹,孔令兴,等.心房颤动患者射频消融治疗前后肺静脉间嵴部宽度的变化[J].临床放射学杂志,2013,32(5):648-651.
[33]	姜其钧,孟小茜,赵亮,等.肺静脉和左房内嵴形态与心房颤动射频消融术后早期心律失常的关系[J].中国心脏起搏与心电生理杂志,2008,22(2):115-118.
[34]	Suenari K,Nakano Y,Hirai Y,et al.Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation:insights from 64-slice multidetector computed tomography[J].Heart Vessels,2013,28(3):360-368.
[35]	陈林,林建华,吴梅琼,等.心房颤动患者导管消融术后环肺静脉疤痕形成情况及其与术后复发的关系[J].中国循环杂志,2018,33(10):995-1000.
[36]	Valderrábano M,Peterson LE,Bunge R,et al.Vein of Marshall ethanol infusion for persistent atrial fibrillation:VENUS and MARS clinical trial design[J].Am Heart J,2019,215:52-61.